Published in Blood Weekly, November 7th, 2002
John V. Hargiss, president and CEO, commented, "The company has set new revenue records for both quarterly and monthly performance. When comparing year-to-date revenue derived solely from the cord blood processing business, the company posted a 57% increase over the comparable prior year's period. August 2002 represents a significant increase over August of last year. Most importantly, August culminated eight consecutive months of sales increases, the last five of which were sequential record setting...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.